For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (791)
-
January 29, 2026 | Comment Edwards-JenaValve sets US precedent on pre-commercial markets, grounds for challenge
...The Sanofi–Maze deal involved Sanofi obtaining an exclusive license to Maze Therapeutics’ experimental...
Sections: DealRisk® and Mergers and Acquisitions
-
January 29, 2026 | Press Round-Up United States Antitrust Press Round-Up United States | 29 Jan 2026
...approval to resolve US price-fixing claims over pork.Reuters- Mylan has been granted a partial win over Sanofi-Aventis...
Sections: Antitrust and Mergers and Acquisitions
-
January 28, 2026 | Official Statement Sanofi, Dynavax Technologies clear US, German antitrust hurdles
...MLex Summary: Sanofi and Dynavax Technologies have received merger clearances from the US and German...
Sections: DealRisk® and Mergers and Acquisitions
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
Already a subscriber? Click here to login